Sign Up to Receive Your Personalised Learning Resources
touchEXPERT OPINIONS
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
Start Learning
Advances in understanding COPD
Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy
Roflumilast Role in the Prevention of Acute Exacerbation in Chronic Obstructive Pulmonary Disease: A Narrative Review
The Changing Landscape of Surgical Treatment for Early-stage Non-small Cell Lung Cancer
Diagnosis and Management of Fibrotic Interstitial Lung Disease: A Primer
Clinical trials and current standard of care in idiopathic pulmonary fibrosis: Steven D. Nathan, ATS 2023
A subgroup analysis of the WILLOW study – brensocatib in bronchiectasis by disease severity: Mark Metersky, ATS 2023
Pulmonary Alveolar Proteinosis: An Overview and Emerging Therapeutics
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy
A study of varenicline and nicotine replacement therapy for smokers admitted to hospital in Australia: Michael Abramson, ERS 2023
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Phenotypic Heterogeneity in Sleep Apnoea
View
Future Directions in Chronic Cough
View
Cytisinicline for Smoking Cessation in Adult Smokers
View
Ensifentrine: an investigational dual phosphodiesterase 3 and 4 inhibitor for COPD: Antonio Anzueto, ATS 2023
View
Ronald Strauss, AAAAI 2023: Unmet needs in the treatment of severe eosinophilic asthma
View
Physiological benefits of pulmonary rehabilitation prior to lung transplantation: David R. Nunley, ATS 2023
View
The ENHANCE trials of ensifentrine in chronic obstructive pulmonary disease: Antonio Anzueto, ATS 2023
View
Non-invasive Ventilation to Provide a More Positive Outlook in Neuromuscular Disease: An Update on the CHEST Guidelines
View
Air pollution and respiratory diseases: Claudia Traidl-Hoffmann, EAACI 2023
View
Acetazolamide to prevent altitude-related adverse health effects in COPD: Michael Furian, ERS 2023
View